OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gold and silver nanoparticles in Alzheimer's and Parkinson's diagnostics and treatments
Edoardo Scarpa, Mariafrancesca Cascione, Anna Griego, et al.
Ibrain (2023) Vol. 9, Iss. 3, pp. 298-315
Open Access | Times Cited: 14

Showing 14 citing articles:

Gold Nanoparticles in Neurological Diseases: A Review of Neuroprotection
Ming‐Chang Chiang, Yuping Yang, Christopher J.B. Nicol, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 4, pp. 2360-2360
Open Access | Times Cited: 18

Nanostructures and nanoparticles as medical diagnostic imaging contrast agents: A review
Nikiwe Mhlanga, Ntsoaki Mphuthi, Hendriëtte Van der Walt, et al.
Materials Today Chemistry (2024) Vol. 40, pp. 102233-102233
Closed Access | Times Cited: 9

Recent advances in nanotechnology for Parkinson’s disease: diagnosis, treatment, and future perspectives
Virendra Kumar Yadav, Seshathiri Dhanasekaran, Nisha Choudhary, et al.
Frontiers in Medicine (2025) Vol. 12
Open Access

About Therapeutic Action of Silver Ions: A Brief Overview
А. А. Анциферова, П. К. Кашкаров
(2025)
Open Access

Metallic Nanomaterials in Parkinson's Disease: A Transformative Approach for Early Detection and Targeted Therapy
Amira I. Mansour, Mariam Hossam Eldin, Ibrahim M. El‐Sherbiny
Journal of Materials Chemistry B (2025)
Open Access

Breaking Barriers in Alzheimer’s Disease: the Role of Advanced Drug Delivery Systems
Devank Shekho, Ritika Mishra, Raj Kamal, et al.
AAPS PharmSciTech (2024) Vol. 25, Iss. 7
Closed Access | Times Cited: 2

Green silver nanoparticles: Prospective nanotools against neurodegenerative cell line model
Valeria De Matteis, Simona Martano, Paolo Pellegrino, et al.
Ibrain (2024) Vol. 10, Iss. 2, pp. 123-133
Open Access | Times Cited: 1

Innovative strategies for overcoming blood-brain barrier challenges in Alzheimer’s disease: A focus on green-synthesized metallic nanoparticles
Kushagra Nagori, Kartik T. Nakhate, Krishna Yadav, et al.
Inorganic Chemistry Communications (2024), pp. 113604-113604
Closed Access | Times Cited: 1

Gasotransmitter nitric oxide imaging in Alzheimer's disease and glioblastoma with diamino-cyclic-metalloiridium phosphorescence probes
Haitao Ding, Li Luo, Liping Su, et al.
Biosensors and Bioelectronics (2023) Vol. 247, pp. 115939-115939
Closed Access | Times Cited: 2

Dansyl‐tagged xanthate ester as a capping agent to synthesize fluorescent silver nanoparticles with binding affinity toward serum albumin
Debashis Barik, Chandrasekhar Pidikaka, Mintu Porel
Photochemistry and Photobiology (2024) Vol. 100, Iss. 4, pp. 980-988
Closed Access

Endothelial cellular senescence and tau accumulation: An interplay full of opportunities?
D. Oliveri, Giorgia Moschetti, Anna Griego, et al.
Ibrain (2024) Vol. 10, Iss. 2, pp. 225-230
Open Access

Nanomedicine in the treatment of Alzheimer’s disease: bypassing the blood-brain barrier with cutting-edge nanotechnology
Nana Dong, Payam Ali‐Khiavi, Nima Ghavamikia, et al.
Neurological Sciences (2024)
Closed Access

Page 1

Scroll to top